February 6, 2018 / 1:13 PM / 3 months ago

BRIEF-Biodelivery Sciences Announces Belbuca Patent Litigation Settlement Agreement With Teva

Feb 6 (Reuters) - Biodelivery Sciences International Inc :

* BIODELIVERY SCIENCES ANNOUNCES BELBUCA PATENT LITIGATION SETTLEMENT AGREEMENT WITH TEVA

* BIODELIVERY SCIENCES - ENTERED INTO SETTLEMENT AGREEMENT WITH TEVA PHARMACEUTICALS USA, INC. AND TEVA PHARMACEUTICALS INDUSTRIES, LTD.

* BIODELIVERY SCIENCES - AGREEMENT RESOLVES BELBUCA (BUPRENORPHINE) BUCCAL FILM (CIII), PATENT LITIGATION AGAINST TEVA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below